Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Accessibility (for Disabled) | 1 |
| Assistive Technology | 1 |
| Biomedicine | 1 |
| Braille | 1 |
| Clinical Diagnosis | 1 |
| Cytology | 1 |
| Drug Therapy | 1 |
| Electronic Publishing | 1 |
| Etiology | 1 |
| Genetic Disorders | 1 |
| Intervention | 1 |
| More ▼ | |
Author
| Bullard-Maxwell, Amanda | 1 |
| Chiarolanzio, Emily | 1 |
| Davis, Alexis Poe | 1 |
| Griffin, Harold | 1 |
| Stone-Hernandez, Regina | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Descriptive | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkDavis, Alexis Poe; Bullard-Maxwell, Amanda; Stone-Hernandez, Regina; Chiarolanzio, Emily; Griffin, Harold – Journal of Visual Impairment & Blindness, 2020
Stargardt Disease was identified by German ophthalmologist Karl Stargardt in 1901. It is the most commonly inherited macular dystrophy condition (Light et al., 2017), with an estimated worldwide prevalence of 1 in 8,000 to 1 in 10,000 (Cai et al., 2018). Stargardt Disease is the juvenile version of macular degeneration (Daly, 2014), with its early…
Descriptors: Genetic Disorders, Visual Impairments, Clinical Diagnosis, Etiology
